SERPINA7 and metabolic dysfunction-associated steatotic liver disease: To test the impact of activating lipophagy on NAFLD/NASH pathology, the LDTS-eLIR construct was engineered into serotype 8 adeno-associated virus (AAV8) with liver-specific thyroxine-binding globulin promoter (pTBG).